THANK YOU FOR SUBSCRIBING
Identifying human ailments via genome sequencing holds maximum accuracy, allowing medical experts to treat and cure patients at an early stage.
FREMONT, CA: Diseases like genetic disorders and cancer, with their increased mortality, are fuming threats to society, and rectifying them is critical to maintaining the harmony of an ecosystem. Following the seamless developments in genetic technologies since the previous decades, addressing these hindrances has likely emerged as a limited possibility in the healthcare sector. That is, after the discovery of DNA structure, geneticists all over the globe are facilitating feasible inventions in the sector via genetic engineering. Along with this, the process of sequencing a human genome has evolved from taking 13 years to three days, with the investment costing only USD 1,000.
Given the seamless possibilities it has favoured in genetic diagnostics, it is no surprise that scientists are inventing new opportunities. However, these surging advancements have likely opened up uncertainties in genetic science in terms of economic, environmental, and ethical issues. With the sequential genome becoming more safe, relative, and high-paced, the complexities that accumulate in procedures like testing and genome editing are deduced accordingly, in addition to facilitating a technology-driven approach for individuals as organisations.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
According to various researchers, nearly 70 per cent of the global population is interested in genetic technologies that have carved their way into the ecosystem through genetic testing to critically identify the gene variants inherited. That is, it enables a plethora of applications such as the diagnosis of rare diseases and commercial services that are made possible by incorporating medical information and family history. Besides, it scrutinises the DNA of large numbers of people, thereby enabling a deliberate understanding of the possible effects that genes may often encounter. As a result, tailored treatments to work with individual genetic makeups are being radically developed to effectively alter genes within patients suffering from disorders.
Wherein, genetic testing is used in a variety of settings, with patients providing a blood sample, which is often analysed for a gene or linked to a specific disorder, or sometimes even an individual's genetic code. Critically processed in laboratories, tests for individual genes with the capability to be processed in real-time are likely making their way into the sector. Though only a few genes are tested, a whole genome approach overlooks and detects every letter in an individual's DNA. This approach considerably encompasses the 100,000 Genomes Project, thus focusing on cancer and several other rare ailments accordingly.
Moreover, scientists from all over the Asia-Pacific region have concluded that nearly 84 per cent of individuals rely on the idea of harnessing genome sequencing to spot the risks of life-threatening diseases within human beings.
More in News